TCM
BLUE

Tekla Capital Management’s bluebird bio BLUE Stock Holding History

Tekla Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,500
Closed -$4.54M – 204
2020
Q3 		$4.54M Hold
6,500
– – 0.17% 109
2020
Q2 		$5.14M Hold
6,500
– – 0.2% 99
2020
Q1 		$3.87M Sell
6,500
-887
-12% -$864K 0.18% 101
2019
Q4 		$8.4M Sell
7,387
-3,443
-32% -$3.74M 0.32% 74
2019
Q3 		$12.9M Buy
10,830
+2,962
+38% +$4.52M 0.56% 44
2019
Q2 		$13M Buy
7,868
+841
+12% +$1.45M 0.53% 43
2019
Q1 		$14.3M Sell
7,027
-572
-8% -$1.01M 0.58% 40
2018
Q4 		$9.76M Buy
7,599
+822
+12% +$1.26M 0.42% 47
2018
Q3 		$12.8M Buy
6,777
+1,203
+22% +$2.49M 0.46% 51
2018
Q2 		$11.3M Buy
5,574
+455
+9% +$1.04M 0.43% 52
2018
Q1 		$11.3M Buy
5,119
+1,483
+41% +$3.77M 0.44% 50
2017
Q4 		$8.39M Buy
3,636
+2,611
+255% +$5.3M 0.32% 63
2017
Q3 		$1.82M Hold
1,025
– – 0.07% 125
2017
Q2 		$1.39M Sell
1,025
-2,784
-73% -$3.36M 0.05% 126
2017
Q1 		$4.49M Hold
3,809
– – 0.17% 89
2016
Q4 		$3.04M Hold
3,809
– – 0.13% 91
2016
Q3 		$3.35M Hold
3,809
– – 0.13% 102
2016
Q2 		$2.14M Hold
3,809
– – 0.09% 128
2016
Q1 		$2.1M Hold
3,809
– – 0.09% 121
2015
Q4 		$3.17M Sell
3,809
-3,444
-47% -$3.44M 0.11% 104
2015
Q3 		$8.04M Buy
7,253
+4,096
+130% +$7.47M 0.29% 78
2015
Q2 		$6.88M Sell
3,157
-1,052
-25% -$2.14M 0.25% 74
2015
Q1 		$6.58M Hold
4,209
– – 0.26% 73
2014
Q4 		$5M Sell
4,209
-9,141
-68% -$6.11M 0.23% 72
2014
Q3 		$6.21M Buy
13,350
+9,141
+217% +$4.22M 0.29% 72
2014
Q2 		$2.1M Sell
4,209
-1,500
-26% -$481K 0.19% 54
2014
Q1 		$1.68M Buy
+5,709
New +$1.73M 0.17% 56

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Tekla Capital Management's BLUE Position: Q4 2020 in Review

Tekla Capital Management sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 6,500 shares — an estimated $4.54M sold.

Tekla Capital Management first reported a position in BLUE in Q1 2014 and held it in 27 quarters. The position peaked at $14.3M in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Tekla Capital Management reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Tekla Capital Management sold 6,500 bluebird bio shares in Q4 2020, an estimated $4.54M.
  • Tekla Capital Management first reported a position in bluebird bio in Q1 2014 and held it in 27 quarters.
  • Tekla Capital Management's bluebird bio position peaked at $14.3M in Q1 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Tekla Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.